JP2022513152A5 - - Google Patents
Info
- Publication number
- JP2022513152A5 JP2022513152A5 JP2021530284A JP2021530284A JP2022513152A5 JP 2022513152 A5 JP2022513152 A5 JP 2022513152A5 JP 2021530284 A JP2021530284 A JP 2021530284A JP 2021530284 A JP2021530284 A JP 2021530284A JP 2022513152 A5 JP2022513152 A5 JP 2022513152A5
- Authority
- JP
- Japan
- Prior art keywords
- mypop
- cancer
- seq
- myb
- transcription factor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16/206,526 | 2018-11-30 | ||
| US16/206,526 US20200174016A1 (en) | 2018-11-30 | 2018-11-30 | Myb-related transcription factor (mypop) as diagnostic marker and therapeutic target for tumor therapy |
| PCT/EP2019/082845 WO2020109439A1 (en) | 2018-11-30 | 2019-11-28 | Myb-related transcription factor (mypop) as diagnostic marker and therapeutic target for tumor therapy |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022513152A JP2022513152A (ja) | 2022-02-07 |
| JP2022513152A5 true JP2022513152A5 (cg-RX-API-DMAC7.html) | 2023-01-11 |
| JP7642538B2 JP7642538B2 (ja) | 2025-03-10 |
Family
ID=68848224
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021530284A Active JP7642538B2 (ja) | 2018-11-30 | 2019-11-28 | 腫瘍療法の診断マーカー及び治療標的としてのMyb関連転写因子(MYPOP) |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US20200174016A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3887550B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7642538B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3121047A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2020109439A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN117164693A (zh) * | 2022-05-28 | 2023-12-05 | 上海交通大学医学院附属仁济医院 | 真核翻译起始因子4a1截短体及用途和检测方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2721179A4 (en) * | 2011-06-16 | 2014-10-01 | Caris Life Sciences Luxembourg Holdings S A R L | BIOMARKER COMPOSITIONS AND METHOD THEREFOR |
-
2018
- 2018-11-30 US US16/206,526 patent/US20200174016A1/en not_active Abandoned
-
2019
- 2019-11-28 US US17/296,820 patent/US20220003783A1/en active Pending
- 2019-11-28 WO PCT/EP2019/082845 patent/WO2020109439A1/en not_active Ceased
- 2019-11-28 JP JP2021530284A patent/JP7642538B2/ja active Active
- 2019-11-28 CA CA3121047A patent/CA3121047A1/en active Pending
- 2019-11-28 EP EP19817974.9A patent/EP3887550B1/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7507532B2 (en) | Cancer specific gene MH15 | |
| WO2014017491A1 (ja) | Cep55遺伝子とret遺伝子との融合遺伝子 | |
| JPWO2014007369A1 (ja) | Fgfr2融合遺伝子 | |
| CN101246169B (zh) | 口腔鳞癌诊断试剂、试剂盒及防治药物 | |
| KR20080114683A (ko) | 질병에 대한 바이오마커로서의 지방생성 아데노바이러스 | |
| JP2023123748A (ja) | 転移性癌の診断及び治療の方法 | |
| CN109022461B (zh) | 一种PTEN基因的上游开放阅读框45aa-uORF核苷酸序列及其编码的多肽的应用 | |
| CN101768214B (zh) | 一种人肿瘤标志物-Tim17多肽及其用途 | |
| US20160267244A1 (en) | Methods of predicting cancer lethality using replikin counts | |
| WO2009116860A1 (en) | Markers providing prognosis of metastasis among cancer patients | |
| CN111139299B (zh) | Josd2蛋白在制备治疗恶性肿瘤药物中的应用 | |
| EP2320932B1 (en) | Methods of predicting cancer lethality using replikin counts | |
| CN113528667B (zh) | 一种骨巨细胞瘤的诊断方法 | |
| CN111424092B (zh) | 一种检测基因及其应用 | |
| CN111617247A (zh) | 表皮生长因子受体激酶底物8类蛋白3在增强多靶点激酶抑制剂疗效中的用途 | |
| JP5316749B2 (ja) | シスプラチン耐性遺伝子診断方法及びシスプラチン治療効果遺伝子診断キット | |
| EP1905780B1 (en) | Cancer suppressing agent | |
| CN107723369B (zh) | Setd1b蛋白及其编码基因在肝癌诊断治疗中的应用 | |
| CN109022462B (zh) | 一种PTEN基因的上游开放阅读框31aa-uORF核苷酸及其编码的多肽的应用 | |
| CN112661826A (zh) | 小肽ERpeptide及其在急性髓系白血病中的应用 | |
| WO2021043340A2 (zh) | 一种肿瘤标志物aquaporin 2蛋白及其应用 | |
| JP6839707B2 (ja) | Gpr160を過剰発現する癌の予防、診断および治療 | |
| JP5622156B2 (ja) | シスプラチン耐性遺伝子診断方法及びシスプラチン治療効果遺伝子診断キット | |
| JP2022513152A (ja) | 腫瘍療法の診断マーカー及び治療標的としてのMyb関連転写因子(MYPOP) | |
| CN113398270B (zh) | 一种治疗骨巨细胞瘤的方法 |